ArticleCell death and differentiation2024

FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism.

Huixian Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.